Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DUSP5 divergent transcript (DUSP5-DT, LOC105378482) refers to an annotated genomic transcript near or antisense to DUSP5, but there is currently no evidence that it encodes a functional protein or has established biological or disease relevance. This entity is not recognized as a therapeutic target, nor are any drug interactions or biomarker roles described in the scientific literature. Explanation and context: - DUSP5 encodes dual specificity phosphatase 5, a well-characterized enzyme involved in MAPK/ERK signal regulation and sometimes reported in the context of diseases such as cancer[1][2][3][4][5]. However, "DUSP5 divergent transcript" (DUSP5-DT, LOC105378482) is a different genomic entry, not equivalent to DUSP5. - Divergent transcripts are typically named for their orientation near a gene of interest (here, DUSP5), but most have unclear or uncharacterized functions and do not represent classic therapeutic targets[1]. - There are no known drugs, mechanisms, biomarker uses, or disease associations specifically linked to DUSP5-DT or LOC105378482 in the available literature. - This transcript is not present in major therapeutic target or drug discovery databases, nor is it discussed in published functional genomics or pharmacology studies. - If your query intended to target DUSP5 (the protein-coding enzyme), rather than DUSP5-DT, see the canonical DUSP5 entries for disease, mechanism, and drug-related information[1][2][3][4][5]. Note: This entry appears to be a genomic annotation artifact or a minimally characterized non-coding RNA, not a therapeutic target. If you need information on DUSP5, the enzyme, please clarify the request.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DUSP5 divergent transcript (DUSP5-DT).